ASH 25th ANNUAL SCIENTIFIC MEETING AND EXPOSITION 2010May 1 - 4, 2010
Location: New York Hilton1335 Avenue of the AmericasNew York, New York
PRESS BRIEFING SCHEDULE
Highlights of ASH – Saturday , May 1 (2:00-3:00 p.m.)•Overview of key sessions•Comparison of community and policy-driven hypertension interventions
Future of Hypertension Treatment – Sunday, May 2 (9:00-10:00 a.m.) •Risk of cardiovascular events with coexisting prehypertension and prediabetes •Examining genetic variations in prehypertensive twins•Structural cardiovascular changes observed in pre-diabetes•LVMI as a predictor of renal outcomes•Identifying optimal blood pressure control in a clinical practice setting
Topics of Interest – Monday, May 3 (11:00 a.m. - 12:00 p.m.)•International Society on Hypertension in Blacks (ISHIB) Guidelines Update•Short sleep duration as a predictor of stroke in elderly hypertensive patients•Impact of genetic variation in salt-sensitive hypertensives•Indicators of masked hypertension in children and adolescents
Late Breaking Clinical Trial Overview – Monday, May 3 (12:15 - 1:00 p.m.)•ACCORD Trial: Effects of Intensive Blood Pressure Control on Stroke and Cardiovascular Events •Results of Once-Daily, Low-Dose, Controlled Release Phentermine/Topiramate (Phen/TPM) for Blood Pressure and Weight Loss in Overweight/Obese Patients •Results of Double-Blind Randomized Study Comparing Chlorthalidone and Hydrochlorothiazide Combined with Azilsartan Medoxomil in Primary Hypertension•Results of Rheos Baroreflex Activation Therapy for Blood Pressure Reduction in Patients with Resistant Hypertension •A Genetic Variant of the Atrial Natriuretic Peptide Gene and Associated Risk for Cardiometabolic Disease
ASH is also proud to present its third annual Hypertension Community Outreach Initiative, which will provide hypertension screening and education to empower the local New York community to take control of their cardiovascular health. The program will also provide in-service training to approximately 500 medical professionals to learn practical approaches to clinical treatment of hypertension for their patients.
To register for the meeting or to receive embargoed materials, please contact the Press Room Managers:
Jennifer Anello Chamberlain Healthcare Public RelationsTel: 1 212-364-0434[email protected]
Nancie SteinbergChamberlain Healthcare Public RelationsTel: 212-884-0667 [email protected]
About the American Society of Hypertension: The American Society of Hypertension (ASH) is the largest U.S. professional organization of scientific investigators and healthcare professionals committed to eliminating hypertension and its consequences. ASH is dedicated to promoting strategies to prevent hypertension and to improving the care of patients with hypertension and associated disorders. The Society serves as a scientific forum that bridges current hypertension research with effective clinical treatment strategies for patients.
RSS